Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

Published:2015-10-26 Issue:2 Volume:1 Page:133-136
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Jarow Jonathan¹,Maher V. Ellen²,Tang Shenghui³,Ibrahim Amna²,Kim Geoffrey²,Sridhara Rajeshwari³,Pazdur Richard²

Affiliation:

1. Office of Medical Policy, Center for Drug Evaluation and Research, FDA, MD, USA

2. Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, FDA, MD, USA

3. Office of Biostatistics, Center for Drug Evaluation and Research, FDA, MD, USA

Publisher

IOS Press

Subject

Urology,Oncology

Reference5 articles.

1. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.;Nielsen;Cancer,2014

2. Non-invasive papillary urothelial neoplasms: The WHO/ISUP classification system;Miyamoto;Pathol Int,2010

3. Current approaches to the management of non-muscle invasive bladder cancer: Comparison of current guidelines and recommendations;Persad;Eur Urol Supplements,2008

4. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study;Lamm;J Urol,2000

5. Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG;Lerner;Bladder Cancer,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?;Current Opinion in Urology;2024-08-20

2. Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG‐treated disease;International Journal of Urology;2023-07-31

3. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up;European Urology Focus;2023-03

4. Optimizing Clinical Trial Design for Patients with Non–muscle-invasive Bladder Cancer;European Urology;2022-07

5. Clinical Trials in Bladder and Upper Tract Cancer – Bladder Cancer Disease States;Bladder Cancer;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3